Skip to main content
. 2022 Dec 31;2022:6926510. doi: 10.1155/2022/6926510

Table 2.

Laboratory examination of participants stratified according to AF status.

Characteristic Sinus rhythm (n = 110) Paroxysmal AF(n = 113) Pa value Persistent AF(n = 136) Pb value Pc value
RBC (109/l) 4.7 (4.4–5.0) 4.7 (4.4–5.0) 0.712 4.8 (4.5–5.2) 0.014 0.033
WBC (109/l) 6.5 (5.6–7.7) 6.4 (5.7–7.6) 0.872 6.6 (5.5–7.5) 0.844 0.827
PLT (1012/l) 237.5 (206.0–281.0) 215.0 (184.0–246.0) 0.001 210.0 (178.5–243.5) <0.001 0.393
Hb (g/l) 144.0 (135.0–155.0) 148.0 (139–160) 0.012 152.0 (142.0–162.0) <0.001 0.155
CREA (umol/l) 62.1 (52.4–75.2) 69.9 (59.8–80.2) 0.001 74.0 (63.6–82.9) <0.001 0.116
GLU (mmol/l) 5.2 (4.9–5.8) 5.5 (5.1–6.1) 0.004 5.5 (5.1–6.6) <0.001 0.190
GA (%) 13.4 (12.4–14.8) 14.1 (13.3–15.3) 0.013 14.3 (13.0–15.9) 0.008 0.651
HCY (umol/l) 11.8 (9.2–14.1) 12.6 (10.7–15.2) 0.059 13.7 (11.7–17.8) <0.001 0.015
TIMP-1 (ng/ml) 67.4 (56.9–81.3) 89.7 (70.6–115.5) <0.001 127.3 (87.0–173.7) <0.001 <0.001
sST2 (pg/ml) 9.1 (6.7–12.4) 14.0 (10.4–20.8) <0.001 19.0 (13.1–27.8) <0.001 <0.001
BNP (pg/ml) 32.0 (10.0–74.0) 67.0 (32.0–123.0) <0.001 125.0 (87.0–215.0) <0.001 <0.001
ALT (U/l) 18.5 (14.0–29.0) 21.0 (16.0–29.0) 0.222 21.0 (15.5–29.0) 0.303 0.766
AST (U/l) 21.5 (18.0–26.0) 22.0 (18.0–26.0) 0.549 22.0 (18.0–28.0) 0.253 0.585
GGT 23.0 (16.0–40.0) 26.0 (18.0–37.0) 0.272 30.5 (22.0–39.0) 0.009 0.122
TP (g/l) 74.9 (70.8–77.4) 71.4 (67.0–75.4) <0.001 72.7 (68.8–75.8) 0.003 0.189
Alb (g/l) 47.0 (44.1–49.4) 45.3 (42.5–47.8) 0.002 44.9 (42.6–47.3) <0.001 0.513
Glo (g/l) 27.6 (24.1–30.1) 26.2 (23.1–28.7) 0.026 27.3 (25.0–30.2) 0.772 0.010
Tbil (umol/l) 10.9 (8.1–14.6) 12.8 (9.9–16.8) 0.001 14.3 (10.9–20.0) <0.001 0.029
Dbil (umol/l) 3.0 (2.3–4.0) 3.5 (2.5–4.5) 0.099 4.4 (3.2–6.3) <0.001 <0.001
Ibil (umol/l) 8.0 (4.8–10.9) 10.0 (6.9–12.8) 0.001 10.3 (6.8–14.0) <0.001 0.532
LDH (U/l) 183 (160–208.0) 183.0 (159.0–208.0) 0.810 194.0 (174.5–219.5) 0.012 0.004
TG (mmol/l) 1.3 (0.9–2.0) 1.5 (1.0–2.3) 0.103 1.2 (0.9–1.8) 0.800 0.031
Tcho (mmol/l) 4.7 (3.9–5.5) 4.4 (3.9–5.2) 0.176 4.2 (3.7–4.9) 0.001 0.048
sdLDLc 0.7 (0.5–1.0) 0.8 (0.5–1.1) 0.207 0.7 (0.4–1.1) 0.510 0.057
LDL-c (mmol/l) 3.0 (2.3–3.5) 2.7 (2.1–3.4) 0.415 2.4 (1.7–3.1) 0.002 0.022
HDL-c (mmol/l) 1.2 (1.1–1.5) 1.2 (1.0–1.4) 0.001 1.2 (1.0–1.4) 0.089 0.109
hs-CRP (mg/l) 1.0 (0.5–1.9) 0.8 (0.5–1.9) 0.871 1.2 (0.6–3.1) 0.019 0.022
D-dimer (ng/ml) 83.0 (52.0–120.0) 73.0 (44.0–106.0) 0.187 71 (40.0–133.0) 0.408 0.807
FDP (ug/ml) 0.4 (0.1–0.7) 0.4 (0–0.7) 0.453 0.3 (0–0.8) 0.939 0.583
FIB (g/l) 2.9 (2.5–3.3) 3.0 (2.5–3.4) 0.391 3 (2.7–3.4) 0.105 0.527
HCT (%) 42.1 (39.4–44.6) 42.1 (40.5–44.7) 0.379 43.4 (41.3–46.0) 0.001 0.011
MCV (fl) 88.6 (86.2–90.7) 90.3 (88.1–92.5) 0.001 90.5 (88.1–92.9) 0.001 0.752
MCH (pg) 30.5 (29.8–31.7) 31.7 (30.7–32.8) <0.001 31.3 (30.5–32.6) <0.001 0.162
MCHC (g/l) 342.5 (334.0–352.0) 351.0 (341.0–360.0) <0.001 344.0 (337.5–356.0) 0.186 0.017
RDW-SD (fl) 41.8 (40.4–43.5) 42.3 (41.0–44.4) 0.065 42.7 (41.4–45.1) 0.004 0.245
RDW-CV (%) 13.0 (12.6–13.4) 13.0 (12.7–13.4) 0.811 13.1 (12.7–13.6) 0.145 0.222
MPV (fl) 10.7 (10.0–11.4) 10.6 (10.1–11.3) 0.930 10.7 (10.0–11.1) 0.378 0.489
PCT (%) 0.3 (0.2–0.3) 0.2 (0.2–0.3) 0.001 0.2 (0.2–0.3) <0.001 0.333
PDW (%) 13.2 (12.0–15.2) 12.5 (11.6–14.3) 0.043 13.3 (11.8–15.4) 0.898 0.032
PLCR 30.2 (24.8–36.6) 29.4 (25.4–35.5) 0.665 29.8 (24.9–34.1) 0.276 0.619

WBC: white blood cell; RBC: red blood cell; PLT: platelet count; Hb: hemoglobin; UA: uric acid; CREA: creatinine; Glu: fasting blood glucose; GA: glycated albumin; HCY: homocysteine; TIMP-1: tissue inhibitors of metalloproteinase-1; sST2: soluble suppression of tumorigenicity 2; BNP: B-type natriuretic peptide; ALT: alanine aminotransferase; AST: aspartate transaminase; TP: total protein; Alb: albumin; Glo: globulin; Tbil: total bilirubin; Dbil: direct bilirubin; Ibil: indirect bilirubin; LDH: lactate dehydrogenase; TG: triacylglycerol; Tcho: total cholesterol; LDL-c: low-density lipoprotein cholesterol; HDL-c: high density lipoprotein cholesterol; LP(a): lipoprotein(a); FFA: free fatty acid; C1q: anti-complement 1q antibody; hs-CRP: high-sensitivityC-reactive protein; FDP: fibrinogen degradation products; FIB: fibrinogen; HCT: hematocrit; MCV: mean red blood cell volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW-SD: red blood cell distribution width-standard deviation; RDW-CV: red blood cell distribution width-cell volume; MPV: mean platelet volume; PCT: platelet hematocrit; PDW: platelet distribution width; Pa: paroxysmal vs. control, Pb: persistent vs. control, and Pc: persistent vs. paroxysmal.